Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11

被引:0
作者
Misselwitz, J
Karch, H
Bielazewska, M
John, U
Ringelmann, F
Rönnefarth, G
Patzer, L
机构
[1] Univ Jena, Dept Pediat, Jena, Germany
[2] Univ Hosp Munster, Inst Hyg, Munster, Germany
关键词
cluster; Escherichia coli O26 : H11; hemolytic-uremic syndrome; Shiga toxin;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The epidemiology and clinical characteristics of the hemolytic-uremic syndrome (HUS) caused by Escherichia coli O157:H7 are well-known, but HUS attributable to non-O157:H7 Shiga toxin (Stx)-producing E. coli (STEC) are less thoroughly described. Here we report a cluster of HUS cases caused by STEC O26011 the most common non-O157:H7 STEC isolated from sporadic cases of HUS in Europe. Methods. Three children between 13 and 17 months of age, living in the same small town, developed HUS within an interval of 5 days. We present clinical and microbiologic data on the patients and their infecting isolates. Results. The clinical course ranged from mild uncomplicated HUS to severe HUS complicated by multiorgan involvement. Microbiologic investigation demonstrated STEC of serotype O26:1111 in stools of all the patients. The phenotypic and molecular characterization of the STEC O26:1111 isolates demonstrated that these strains were identical and, unusual for STEC O26, they harbored the stx2 but not the stx1 gene. None of the patients had evidence of STEC O157:H7 infection either by culture or by E. coli O157 serology. The source of the STEC O26:H11 infection was undetermined. Conclusions. Our results demonstrate that diagnostic procedures based on the detection of stx genes and/or Stx production and subsequent sub-typing of the isolates using molecular methods are necessary to identify such outbreaks caused by non-O157:H7 STEC.
引用
收藏
页码:349 / 354
页数:6
相关论文
共 40 条
  • [1] Shiga-like toxin-producing Escherichia coli O111 and associated hemolytic-uremic syndrome: A family outbreak
    Banatvala, N
    Debeukelaer, MM
    Griffin, PM
    Barrett, TJ
    Greene, KD
    Green, JH
    Wells, JG
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (11) : 1008 - 1011
  • [2] The United States national prospective hemolytic uremic syndrome study: Microbiologic, serologic, clinical, and epidemiologic findings
    Banatvala, N
    Griffin, PM
    Greene, KD
    Barrett, TJ
    Bibb, WF
    Green, JH
    Wells, JG
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (07) : 1063 - 1070
  • [3] Bielaszewska M, 1996, CLIN NEPHROL, V46, P42
  • [4] Non-O157:H7 Shiga toxin (verocytotoxin)-producing Escherichia coli strains:: epidemiological significance and microbiological diagnosis
    Bielaszewska, M
    Karch, H
    [J]. WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, 2000, 16 (8-9) : 711 - 718
  • [5] INDIRECT HEMAGGLUTINATION ASSAY FOR DIAGNOSIS OF ESCHERICHIA-COLI O157 INFECTION IN PATIENTS WITH HEMOLYTIC-UREMIC SYNDROME
    BITZAN, M
    KARCH, H
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (05) : 1174 - 1178
  • [6] BLANCO JE, 1996, ALIMENTARIA, V275, P109
  • [7] BOCKEMUHL J, 1998, BUNDESGESUNDHB S OCT, P2
  • [8] BOCKEMUHL J, 1997, BUNDESGESUNDHEITSBLA, V6, P194
  • [9] Possible person-to-person transmission of Escherichia coli O111 - Associated hemolytic uremic syndrome
    Boudailliez, B
    Berquin, P
    MarianiKurkdjian, P
    Ilef, DD
    Cuvelier, B
    Capek, I
    Tribout, B
    Bingen, E
    Piussan, C
    [J]. PEDIATRIC NEPHROLOGY, 1997, 11 (01) : 36 - 39
  • [10] Cholelithiasis following Escherichia coli O157:H7-associated hemolytic uremic syndrome
    Brandt, JR
    Joseph, MW
    Fouser, LS
    Tarr, PI
    Zelikovic, I
    McDonald, RA
    Avner, ED
    McAfee, NG
    Watkins, SL
    [J]. PEDIATRIC NEPHROLOGY, 1998, 12 (03) : 222 - 225